Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals-Reference-Cited by-同舟云学术

Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals

Published:2021-07 Issue:5 Volume:5 Page:
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Abdulrehman Jameel¹^ORCID,Zarabi Sahar²,Elbaz Carolyne³^ORCID,Wit Kerstin⁴⁵^ORCID,Lin Yulia⁶⁷⁸^ORCID,Sholzberg Michelle⁹^ORCID,Selby Rita¹⁰^ORCID

Affiliation:

1. Division of Hematology Department of Medicine University Health Network University of Toronto Toronto ON Canada

2. University of Toronto Medical School Toronto ON Canada

3. Department of Medicine McGill University Montreal QC Canada

4. Department of Medicine and Department of HEI McMaster University Hamilton ON Canada

5. Department of Emergency Medicine Queen’s University Kingston ON Canada

6. Department of Laboratory Medicine and Molecular Diagnostics Sunnybrook Health Sciences Centre Toronto ON Canada

7. Department of Laboratory Medicine & Pathobiology University of Toronto Toronto ON Canada

8. University of Toronto Quality in Utilization, Education and Safety in Transfusion Research Program Toronto ON Canada

9. Department of Medicine Department of Laboratory Medicine and Pathobiology St. Michael’s Hospital Li Ka Shing Knowledge Institute University of Toronto Toronto ON Canada

10. Departments of Laboratory Medicine and Pathobiology & Department of Medicine University of Toronto Toronto ON Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12535

Reference23 articles.

1. Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

2. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

3. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

4. Overview of the New Oral Anticoagulants

5. Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding;European Journal of Anaesthesiology;2024-04-04

2. ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic events;European Heart Journal Supplements;2024-04

3. Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes;Thrombosis Research;2023-08

4. A Historical Perspective on the Reversal of Anticoagulants;Seminars in Thrombosis and Hemostasis;2022-09-02